The World Market for Flow Cytometry in IVD Applications

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
The World Market for Flow Cytometry in IVD Applications

Dublin, Aug. 1, 2014 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/ps...rld_market ) has announced the addition of the "The World Market for Flow Cytometry in IVD Applications" report to their offering.

Flow cytometers are powerful reference lab instruments that are now an important component of advanced IVD labs in developed nations. They are advanced diagnostic instruments for cancer diagnostics, but their newer clinical applications included the commercialization and refinement of HIV testing and monitoring through CD4/CD8 counts. Until recently flow cytometry has been used exclusively for these purposes. Other applications are seeing procedure growth.

This report, The World Market for Flow Cytometry in In Vitro Diagnostic Applications, is Kalorama's complete market analysis of this important diagnostics segment.

  • Market and Forecast 2013-2018 for Flow Cytometry in IVD
  • Breakout by Application (Cancer, HIV, Organ Transplant, Other)
  • Regional Breakout (US, EUR, ROW)
  • Country Markets for Flow Cytometry
  • Market Share by Company
  • Products on the Market


Key Company Profiles

Flow cytometry is useful in biotechnology, drug development, and clinical research. This report focuses only on IVD applications for flow. As part of its analysis, Kalorama considers growth drivers for the flow cytometry market in diagnostics, examines competitive moves by companies in the market, and reimbursment trends that will affect growth long-term. Profiled manufacturers include:

  • Beckman Coulter
  • Becton, Dickinson
  • EMD Millipore
  • Life Technologies
  • Luminex Corporation
  • Miltenyi Biotech
  • Partec Gmbh
  • Sony Biotechnology ( iCyt )


Key Topics Covered:

ONE: EXECUTIVE SUMMARY

TWO: INTRODUCTION

THREE: MARKET ANALYSIS

FOUR: COMPANY PROFILES


For more information visit http://www.researchandmarkets.com/research/ps...rld_market

Research and Markets Laura Wood, Senior Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Healthcare and Medical Devices, Oncology

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Madrigal Pharmaceuticals Rewards New Employees with Equity Awards

Updated Category News Views 100

Overview of Equity Inducement Awards Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a leading biopharmaceutical organization, has recently initiated equity inducement awards to welcome new talent to its dynamic team. This initiative demonstrates Madrigal's commitment to fostering a strong workforce geared towards tackling significant health challenges related to metabolic...

Continue Reading
Boston Metal Welcomes Roy Harvey to Enhance Board Leadership

Updated Category News Views 202

Boston Metal Appoints Industry Leader Roy Harvey Boston Metal, a prominent technology company that is transforming the landscape of global metals production, has made a significant move by appointing Roy Harvey to its Board of Directors. This decision is pivotal as Boston Metal gears up for the commercial rollout of its groundbreaking Molten Oxide Electrolysis (MOE)...

Continue Reading
RBL LLC Partners with Carnrite Ventures for Biotech Growth

Updated Category News Views 125

RBL LLC Partners with Carnrite Ventures for Biotech Growth RBL LLC, a leading biotech venture creation studio, is excited to announce a significant investment from Carnrite Ventures. This partnership aims to enhance the rapid development of their robust pipeline of innovative therapeutic companies. According to Paul Wotton, the managing partner at RBL, "Carnrite's...

Continue Reading
OncoC4 and AcroImmune Merger: A Milestone in Immunotherapy

Updated Category News Views 106

Introducing the OncoC4 and AcroImmune Merger OncoC4, Inc. has just announced a thrilling merger with AcroImmune, a strategic union that promises to significantly boost OncoC4's standing in the biopharmaceutical sector. This collaboration brings together two companies dedicated to pioneering advancements in cancer treatment, with a special focus on developing unique...

Continue Reading
Rezolve AI Celebrates Major Investment Transforming AI Landscape

Updated Category News Views 92

Rezolve AI Excited About $30 Billion AI Investment Rezolve AI (NASDAQ: RZLV), well-known for its cutting-edge AI-driven commerce solutions, is enthusiastic about the recent announcement from Microsoft and BlackRock. These influential tech companies plan to invest $30 billion into AI infrastructure, a decision that could profoundly alter the landscape of the artificial...

Continue Reading